{
  "uid": "bbca3e43",
  "metadata": {
    "Full_Name": "solomon",
    "Age": "78",
    "Gender": "Female",
    "Systolic": "180",
    "Diastolic": "110",
    "Glucose_Level": "376",
    "BMI": "30.8",
    "Duration": "16",
    "Smoking": "Yes",
    "Hypertension": "Yes",
    "Family_History": "Yes",
    "Cholesterol": "230",
    "HbA1c": "8.6",
    "Insulin_Use": "Yes",
    "Physical_Activity": "1",
    "Medication": "Yes"
  },
  "prediction": {
    "predicted_stage": "SEVERE",
    "confidence": 83.6,
    "risk_score": 95.42
  },
  "probs": {
    "cnn": [
      0.01661859080195427,
      0.009372644126415253,
      0.012959725223481655,
      0.9499325752258301,
      0.011116418056190014
    ],
    "ml": [
      0.21136369507961952,
      0.20268235745827803,
      0.19376393050773666,
      0.19047474400645248,
      0.20171527294791336
    ],
    "fused": [
      0.04583035825762507,
      0.03836910264489016,
      0.04008035760254893,
      0.8360139336333661,
      0.03970624786156982
    ]
  },
  "lesion_stats": {
    "exudates": 0.169,
    "hemorrhages": 7.567,
    "cotton_wool": 0.0,
    "microaneurysms": 17.827,
    "neovascularization": 11.424,
    "total_lesion_load": 25.563
  },
  "images": {
    "original": "uploads\\bbca3e43.png",
    "processed": "static\\processed_images\\bbca3e43_processed.png",
    "gradcam": "static/xai_outputs/bbca3e43_gradcam.jpg",
    "lime": "static/xai_outputs/bbca3e43_lime.png",
    "shap": "static/xai_outputs/bbca3e43_shap.png"
  },
  "model_metrics": {
    "Accuracy": 0.947,
    "F1-score": 0.938,
    "AUC/ROC": 0.971
  },
  "generated_at": "2025-11-11T17:14:48.781120+00:00",
  "reports": {
    "patient_en": "Patient: solomon\n\nSummary:\n- Detected stage: SEVERE diabetic retinopathy.\n- Model confidence: 83.6%\n- Estimated retinal risk score: 95.42%\n\nKey findings:\n- Exudates: 0.169%; Hemorrhages: 7.567%; Cotton Wool: 0.0%; Microaneurysms: 17.827%; Neovascularization: 11.424%; Total Lesion Load: 25.563%\n\nAdvice and next steps:\n1. Maintain regular follow-ups with your eye specialist.\n2. Keep blood sugar and blood pressure under control.\n3. Stay active and follow a healthy diet (vegetables, fiber, limit sugar).\n4. If you notice blurred vision, floaters, sudden visual changes or pain, seek urgent care.\n\nLifestyle recommendations:\n- Avoid smoking; maintain hydration and regular sleep.\n- Early attention and good metabolic control reduce the risk of vision loss.\n\nSincerely,\nVisionAI ‚Äî your digital eye health assistant.",
    "doctor_en": "Clinical Report\n\nPatient stage: SEVERE\nModel confidence: 83.6%\nRisk score: 95.42%\n\nFindings:\n- Exudates: 0.169%\n- Hemorrhages: 7.567%\n- Cotton Wool: 0.0%\n- Microaneurysms: 17.827%\n- Neovascularization: 11.424%\n- Total Lesion Load: 25.563%\n\nModel and explainability:\n- Multi-model fusion: CNN ensemble (EfficientNet, ResNet50, ViT) and metadata models (RF, XGBoost, stacked ensemble).\n- Explainability overlays available: GradCAM++, LIME, SHAP ‚Äî review heatmaps to confirm localization.\n\nPerformance metrics:\n- Accuracy: 0.947\n- F1-score: 0.938\n- AUC/ROC: 0.971\n\nClinical recommendations:\n1. Correlate with clinical exam and patient history.\n2. If findings consistent with moderate-severe disease, consider ophthalmology referral and OCT for macular edema assessment.\n3. Review GradCAM/LIME overlays before final grading.\n4. Optimize systemic risk factors (glycemic, BP, lipids).\n",
    "research_en": "Research Notes\n\nUID: bbca3e43\nPredicted stage: SEVERE\nConfidence: 83.6%\nRisk score: 95.42%\n\nModel stack and fusion:\n- CNN ensemble: EfficientNet, ResNet50, ViT\n- Metadata models: Random Forest, XGBoost, Stacked ensemble\n- Fusion method: weighted averaging with risk calibration\n- Device used for inference: CPU\n\nExplainability summary:\n- GradCAM++ / LIME: localize exudates/hemorrhages in the posterior pole.\n- SHAP: systemic features (HbA1c, BMI, BP) show highest importance for risk estimation.\n\nPerformance metrics:\n- Accuracy: 0.947\n- F1-score: 0.938\n- AUC/ROC: 0.971\n\nProbability vector (fused): [0.04583035825762507, 0.03836910264489016, 0.04008035760254893, 0.8360139336333661, 0.03970624786156982]\n\nRecommendations for research:\n1. Validate lesion segmentation against expert masks (dice/IoU metrics).\n2. Add cotton-wool-spot augmentation / labeling to improve detection if false-negatives seen.\n3. Evaluate GradCAM fidelity vs human heatmaps; consider GradCAM region IoU as a metric.\n4. Consider temporal tracking for progressive DR detection (longitudinal data).\n",
    "patient_kn": "‡≤®‡≤Æ‡≤∏‡≥ç‡≤ï‡≤æ‡≤∞ ‡≤∏‡≥ä‡≤≤‡≥ä‡≤Æ‡≤®‡≥ç,\n\n‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ ‡≤Æ‡≤ß‡≥Å‡≤Æ‡≥á‡≤π ‡≤¨‡≤¶‡≤≤‡≤æ‡≤µ‡≤£‡≥Ü‡≤ó‡≤≥‡≥Å ‡≤ï‡≤Ç‡≤°‡≥Å‡≤¨‡≤∞‡≥Å‡≤§‡≥ç‡≤§‡≤µ‡≥Ü. ‡≤∂‡≥Ä‡≤ò‡≥ç‡≤∞‡≤¶‡≤≤‡≥ç‡≤≤‡≥á ‡≤®‡≤ø‡≤Æ‡≥ç‡≤Æ ‡≤ï‡≤£‡≥ç‡≤£‡≤ø‡≤® ‡≤µ‡≥à‡≤¶‡≥ç‡≤Ø‡≤∞‡≤®‡≥ç‡≤®‡≥Å ‡≤≠‡≥á‡≤ü‡≤ø ‡≤Æ‡≤æ‡≤°‡≥Å‡≤µ‡≥Å‡≤¶‡≥Å ‡≤Æ‡≥Å‡≤ñ‡≥ç‡≤Ø.\n\n‡≤™‡≤§‡≥ç‡≤§‡≥Ü‡≤Ø‡≤æ‡≤¶ ‡≤π‡≤Ç‡≤§: ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ ‡≤°‡≤Ø‡≤æ‡≤¨‡≤ø‡≤ü‡≤ø‡≤ï‡≥ç ‡≤∞‡≥Ü‡≤ü‡≤ø‡≤®‡≥ã‡≤™‡≤§‡≤ø.\n\n‡≤∏‡≤Ç‡≤∂‡≥ã‡≤ß‡≤®‡≥Ü‡≤ó‡≤≥ ‡≤∏‡≤æ‡≤∞‡≤æ‡≤Ç‡≤∂: ‡≤π‡≥ä‡≤∞‡≤∏‡≥Ç‡≤∏‡≥Å‡≤µ‡≤ø‡≤ï‡≥Ü‡≤ó‡≤≥‡≥Å 16.9%, ‡≤π‡≥Ü‡≤Æ‡≤∞‡≥á‡≤ú‡≥ç‡≤ó‡≤≥‡≥Å 7.6%, ‡≤π‡≤§‡≥ç‡≤§‡≤ø ‡≤â‡≤£‡≥ç‡≤£‡≥Ü 0.0%, ‡≤Æ‡≥à‡≤ï‡≥ç‡≤∞‡≥ä‡≤Ö‡≤®‡≥ç‡≤Ø‡≥Ç‡≤∞‡≤ø‡≤∏‡≤Æ‡≥ç‡≤ó‡≤≥‡≥Å 17.8%, ‡≤®‡≤ø‡≤Ø‡≥ã‡≤µ‡≤æ‡≤∏‡≥ç‡≤ï‡≥Å‡≤≤‡≤∞‡≥à‡≤∏‡≥á‡≤∂‡≤®‡≥ç 11.4%, ‡≤í‡≤ü‡≥ç‡≤ü‡≥Å ‡≤ó‡≤æ‡≤Ø‡≤¶ ‡≤π‡≥ä‡≤∞‡≥Ü 25.6%.\n‡≤Æ‡≤æ‡≤¶‡≤∞‡≤ø ‡≤µ‡≤ø‡≤∂‡≥ç‡≤µ‡≤æ‡≤∏: N/A.\n‡≤Ö‡≤™‡≤æ‡≤Ø‡≤ï‡≤æ‡≤∞‡≤ø ‡≤Ö‡≤Ç‡≤∂‡≤ó‡≤≥‡≤®‡≥ç‡≤®‡≥Å ‡≤ó‡≤Æ‡≤®‡≤ø‡≤∏‡≤≤‡≤æ‡≤ó‡≤ø‡≤¶‡≥Ü: ‡≤ß‡≥Ç‡≤Æ‡≤™‡≤æ‡≤®, ‡≤Ö‡≤ß‡≤ø‡≤ï ‡≤∞‡≤ï‡≥ç‡≤§‡≤¶‡≥ä‡≤§‡≥ç‡≤§‡≤°, ‡≤¨‡≥ä‡≤ú‡≥ç‡≤ú‡≥Å (BMI ‚â•30).\n\n‡≤Æ‡≥Å‡≤Ç‡≤¶‡≤ø‡≤® ‡≤π‡≤Ç‡≤§‡≤ó‡≤≥‡≥Å: ‡≤π‡≥Ü‡≤ö‡≥ç‡≤ö‡≤ø‡≤® ‡≤Æ‡≥å‡≤≤‡≥ç‡≤Ø‡≤Æ‡≤æ‡≤™‡≤®‡≤ï‡≥ç‡≤ï‡≤æ‡≤ó‡≤ø ‡≤®‡≥á‡≤§‡≥ç‡≤∞‡≤∂‡≤æ‡≤∏‡≥ç‡≤§‡≥ç‡≤∞‡≤¶ ‡≤Ö‡≤™‡≤æ‡≤Ø‡≤ø‡≤Ç‡≤ü‡≥ç‚Äå‡≤Æ‡≥Ü‡≤Ç‡≤ü‡≥ç ‡≤Ö‡≤®‡≥ç‡≤®‡≥Å ‡≤Ü‡≤¶‡≤∑‡≥ç‡≤ü‡≥Å ‡≤¨‡≥á‡≤ó ‡≤ï‡≤æ‡≤Ø‡≥ç‡≤¶‡≤ø‡≤∞‡≤ø‡≤∏‡≤ø.\n\n‡≤®‡≥Ü‡≤®‡≤™‡≤ø‡≤°‡≤ø - ‡≤Ü‡≤∞‡≤Ç‡≤≠‡≤ø‡≤ï ‡≤ó‡≤Æ‡≤®‡≤µ‡≥Å ‡≤®‡≤ø‡≤Æ‡≥ç‡≤Æ ‡≤¶‡≥É‡≤∑‡≥ç‡≤ü‡≤ø‡≤Ø‡≤®‡≥ç‡≤®‡≥Å ‡≤∏‡≤Ç‡≤∞‡≤ï‡≥ç‡≤∑‡≤ø‡≤∏‡≤≤‡≥Å ‡≤∏‡≤π‡≤æ‡≤Ø ‡≤Æ‡≤æ‡≤°‡≥Å‡≤§‡≥ç‡≤§‡≤¶‡≥Ü. üíô",
    "doctor_kn": "‡≤∏‡≥ä‡≤≤‡≥ä‡≤Æ‡≤®‡≥ç‚Äå‡≤ó‡≤æ‡≤ó‡≤ø VisionAI ‡≤ï‡≥ç‡≤≤‡≤ø‡≤®‡≤ø‡≤ï‡≤≤‡≥ç ‡≤µ‡≤∞‡≤¶‡≤ø (‡≤µ‡≤Ø‡≤∏‡≥ç‡≤∏‡≥Å: 78, BMI: 30.8)\n\n‡≤π‡≤Ç‡≤§: ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ ‡≤°‡≤Ø‡≤æ‡≤¨‡≤ø‡≤ü‡≤ø‡≤ï‡≥ç ‡≤∞‡≥Ü‡≤ü‡≤ø‡≤®‡≥ã‡≤™‡≤§‡≤ø.\n‡≤∏‡≤æ‡≤∞‡≤æ‡≤Ç‡≤∂: ‡≤µ‡≥ç‡≤Ø‡≤æ‡≤™‡≤ï‡≤µ‡≤æ‡≤¶ ‡≤∞‡≤ï‡≥ç‡≤§‡≤∏‡≥ç‡≤∞‡≤æ‡≤µ‡≤ó‡≤≥‡≥Å ‡≤Æ‡≤§‡≥ç‡≤§‡≥Å ‡≤∏‡≤ø‡≤∞‡≥Ü‡≤Ø ‡≤Æ‡≤£‡≤ø‡≤ó‡≤≥‡≥Å - ‡≤∏‡≤Ç‡≤≠‡≤µ‡≤®‡≥Ä‡≤Ø ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ NPDR.\n‡≤∏‡≥ç‡≤µ‡≤Ø‡≤Ç‡≤ö‡≤æ‡≤≤‡≤ø‡≤§ ‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤µ‡≤ø‡≤∂‡≥ç‡≤≤‡≥á‡≤∑‡≤£‡≥Ü: ‡≤π‡≥ä‡≤∞‡≤∏‡≥Ç‡≤∏‡≥Å‡≤µ‡≤ø‡≤ï‡≥Ü‡≤ó‡≤≥‡≥Å 16.9%, ‡≤π‡≥Ü‡≤Æ‡≤∞‡≥á‡≤ú‡≥ç‡≤ó‡≤≥‡≥Å 7.6%, ‡≤π‡≤§‡≥ç‡≤§‡≤ø ‡≤â‡≤£‡≥ç‡≤£‡≥Ü 0.0%, ‡≤Æ‡≥à‡≤ï‡≥ç‡≤∞‡≥ä‡≤Ö‡≤®‡≥ç‡≤Ø‡≥Ç‡≤∞‡≤ø‡≤∏‡≤Æ‡≥ç‡≤ó‡≤≥‡≥Å 17.8%, ‡≤®‡≤ø‡≤Ø‡≥ã‡≤µ‡≤æ‡≤∏‡≥ç‡≤ï‡≥Å‡≤≤‡≤∞‡≥à‡≤∏‡≥á‡≤∂‡≤®‡≥ç 11.4%, ‡≤í‡≤ü‡≥ç‡≤ü‡≥Å ‡≤ó‡≤æ‡≤Ø‡≤¶ ‡≤π‡≥ä‡≤∞‡≥Ü 25.6%.\n‡≤µ‡≤ø‡≤∂‡≥ç‡≤µ‡≤æ‡≤∏: N/A, AUC: N/A.\n‡≤µ‡≥ç‡≤Ø‡≤µ‡≤∏‡≥ç‡≤•‡≤ø‡≤§ ‡≤Ö‡≤™‡≤æ‡≤Ø‡≤ó‡≤≥‡≤®‡≥ç‡≤®‡≥Å ‡≤ó‡≥Å‡≤∞‡≥Å‡≤§‡≤ø‡≤∏‡≤≤‡≤æ‡≤ó‡≤ø‡≤¶‡≥Ü: ‡≤ß‡≥Ç‡≤Æ‡≤™‡≤æ‡≤®, ‡≤Ö‡≤ß‡≤ø‡≤ï ‡≤∞‡≤ï‡≥ç‡≤§‡≤¶‡≥ä‡≤§‡≥ç‡≤§‡≤°, ‡≤¨‡≥ä‡≤ú‡≥ç‡≤ú‡≥Å (BMI ‚â•30).\n\n‡≤∂‡≤ø‡≤´‡≤æ‡≤∞‡≤∏‡≥Å: ‡≤§‡≥Å‡≤∞‡≥ç‡≤§‡≥Å ‡≤®‡≥á‡≤§‡≥ç‡≤∞‡≤∂‡≤æ‡≤∏‡≥ç‡≤§‡≥ç‡≤∞‡≤¶ ‡≤â‡≤≤‡≥ç‡≤≤‡≥á‡≤ñ; ‡≤µ‡≥ç‡≤Ø‡≤µ‡≤∏‡≥ç‡≤•‡≤ø‡≤§ ‡≤Ü‡≤™‡≥ç‡≤ü‡≤ø‡≤Æ‡≥à‡≤∏‡≥á‡≤∂‡≤®‡≥ç.\n\n‡≤ó‡≤Æ‡≤®‡≤ø‡≤∏‡≤ø: ‡≤ï‡≥ç‡≤≤‡≤ø‡≤®‡≤ø‡≤ï‡≤≤‡≥ç ‡≤∏‡≤Ç‡≤∂‡≥ã‡≤ß‡≤®‡≥Ü‡≤ó‡≤≥‡≥Å ‡≤Æ‡≤§‡≥ç‡≤§‡≥Å ‡≤∞‡≥ã‡≤ó‡≤ø‡≤Ø ‡≤á‡≤§‡≤ø‡≤π‡≤æ‡≤∏‡≤¶‡≥ä‡≤Ç‡≤¶‡≤ø‡≤ó‡≥Ü ‡≤™‡≤∞‡≤∏‡≥ç‡≤™‡≤∞ ‡≤∏‡≤Ç‡≤¨‡≤Ç‡≤ß‡≤ø‡≤∏‡≤ø. ‡≤≤‡≤≠‡≥ç‡≤Ø‡≤µ‡≤ø‡≤¶‡≥ç‡≤¶‡≤∞‡≥Ü Grad-CAM ‡≤π‡≥Ä‡≤ü‡≥ç‚Äå‡≤Æ‡≥ç‡≤Ø‡≤æ‡≤™‡≥ç‚Äå‡≤ó‡≤≥‡≤®‡≥ç‡≤®‡≥Å ‡≤™‡≤∞‡≤ø‡≤∂‡≥Ä‡≤≤‡≤ø‡≤∏‡≤ø.",
    "research_kn": "‡≤µ‡≤ø‡≤∑‡≤Ø: ‡≤∏‡≥ä‡≤≤‡≥ä‡≤Æ‡≤®‡≥ç\n‡≤®‡≤ø‡≤∞‡≥Ä‡≤ï‡≥ç‡≤∑‡≤ø‡≤§ ‡≤π‡≤Ç‡≤§: ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞\n‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤∏‡≤æ‡≤∞‡≤æ‡≤Ç‡≤∂: ‡≤π‡≥ä‡≤∞‡≤∏‡≥Ç‡≤∏‡≥Å‡≤µ‡≤ø‡≤ï‡≥Ü‡≤ó‡≤≥‡≥Å 16.9%, ‡≤∞‡≤ï‡≥ç‡≤§‡≤∏‡≥ç‡≤∞‡≤æ‡≤µ‡≤ó‡≤≥‡≥Å 7.6%, ‡≤π‡≤§‡≥ç‡≤§‡≤ø ‡≤â‡≤£‡≥ç‡≤£‡≥Ü 0.0%, ‡≤Æ‡≥à‡≤ï‡≥ç‡≤∞‡≥ä‡≤Ö‡≤®‡≥ç‡≤Ø‡≥Ç‡≤∞‡≤ø‡≤∏‡≤Æ‡≥ç‡≤ó‡≤≥‡≥Å 17.8%, ‡≤®‡≤ø‡≤Ø‡≥ã‡≤µ‡≤æ‡≤∏‡≥ç‡≤ï‡≥Å‡≤≤‡≤∞‡≥à‡≤∏‡≥á‡≤∂‡≤®‡≥ç 11.4%, ‡≤í‡≤ü‡≥ç‡≤ü‡≥Å ‡≤ó‡≤æ‡≤Ø‡≤¶ ‡≤π‡≥ä‡≤∞‡≥Ü 25.6%\n‡≤Æ‡≤æ‡≤¶‡≤∞‡≤ø ‡≤µ‡≤ø‡≤∂‡≥ç‡≤µ‡≤æ‡≤∏: N/A, AUC: N/A, GradCAM: ‡≤≤‡≤≠‡≥ç‡≤Ø‡≤µ‡≤ø‡≤≤‡≥ç‡≤≤\n\n‡≤µ‡≤ø‡≤∂‡≥ç‡≤≤‡≥á‡≤∑‡≤£‡≤æ‡≤§‡≥ç‡≤Æ‡≤ï ‡≤ü‡≤ø‡≤™‡≥ç‡≤™‡≤£‡≤ø‡≤ó‡≤≥‡≥Å: ‡≤π‡≥Ü‡≤ö‡≥ç‡≤ö‡≤ø‡≤® ‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤∏‡≤æ‡≤Ç‡≤¶‡≥ç‡≤∞‡≤§‡≥Ü ‡≤Æ‡≤§‡≥ç‡≤§‡≥Å ‡≤π‡≥Ä‡≤ü‡≥ç‚Äå‡≤Æ‡≥ç‡≤Ø‡≤æ‡≤™‡≥ç ‡≤ï‡≤µ‡≤∞‡≥á‡≤ú‡≥ç; ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ NPDR ‡≤∏‡≤Ç‡≤≠‡≤µ‡≤®‡≥Ä‡≤Ø‡≤§‡≥Ü‡≤Ø ‡≤ï‡≤∞‡≥ç‡≤µ‡≥ç‚Äå‡≤ó‡≥Ü ‡≤π‡≥ä‡≤Ç‡≤¶‡≤ø‡≤ï‡≥Ü‡≤Ø‡≤æ‡≤ó‡≥Å‡≤µ ‡≤Æ‡≤æ‡≤¶‡≤∞‡≤ø.\n\n‡≤∏‡≤Ç‡≤∂‡≥ã‡≤ß‡≤®‡≤æ ‡≤∂‡≤ø‡≤´‡≤æ‡≤∞‡≤∏‡≥Å‡≤ó‡≤≥‡≥Å:\n- ‡≤™‡≤∞‡≤ø‡≤£‡≤ø‡≤§ ‡≤Æ‡≥Å‡≤ñ‡≤µ‡≤æ‡≤°‡≤¶‡≥ä‡≤Ç‡≤¶‡≤ø‡≤ó‡≥Ü ‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤∏‡≥Ü‡≤ó‡≥ç‡≤Æ‡≥Ü‡≤Ç‡≤ü‡≥á‡≤∂‡≤®‡≥ç ‡≤Ö‡≤§‡≤ø‡≤ï‡≥ç‡≤∞‡≤Æ‡≤£‡≤µ‡≤®‡≥ç‡≤®‡≥Å ‡≤Æ‡≥å‡≤≤‡≥ç‡≤Ø‡≥Ä‡≤ï‡≤∞‡≤ø‡≤∏‡≤ø.\n- ‡≤π‡≤Ç‡≤§‡≤¶ ‡≤∏‡≤Æ‡≤§‡≥ã‡≤≤‡≤®‡≤µ‡≤®‡≥ç‡≤®‡≥Å ‡≤∏‡≥Å‡≤ß‡≤æ‡≤∞‡≤ø‡≤∏‡≤≤‡≥Å ‡≤Æ‡≥Å‡≤Ç‡≤¶‡≤ø‡≤® ‡≤Æ‡≤∞‡≥Å‡≤§‡≤∞‡≤¨‡≥á‡≤§‡≤ø ‡≤¨‡≥ç‡≤Ø‡≤æ‡≤ö‡≥ç‚Äå‡≤®‡≤≤‡≥ç‡≤≤‡≤ø ‡≤∏‡≥á‡≤∞‡≤ø‡≤∏‡≤ø.\n- ‡≤Æ‡≤æ‡≤®‡≤µ ‡≤ó‡≥ç‡≤∞‡≥á‡≤°‡≤ø‡≤Ç‡≤ó‡≥ç ‡≤π‡≥Ä‡≤ü‡≥ç‚Äå‡≤Æ‡≥ç‡≤Ø‡≤æ‡≤™‡≥ç‚Äå‡≤ó‡≤≥ ‡≤µ‡≤ø‡≤∞‡≥Å‡≤¶‡≥ç‡≤ß GradCAM ‡≤™‡≥ç‡≤∞‡≤¶‡≥á‡≤∂‡≤¶ ‡≤®‡≤ø‡≤∑‡≥ç‡≤†‡≥Ü‡≤Ø‡≤®‡≥ç‡≤®‡≥Å ‡≤Æ‡≥å‡≤≤‡≥ç‡≤Ø‡≤Æ‡≤æ‡≤™‡≤® ‡≤Æ‡≤æ‡≤°‡≤ø."
  }
}